Cited by 193Barrier Structure and Function StudiesAdvanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.

CNS Drug Delivery Systems: Novel Approaches

Pathan, Shadab, Iqbal, Zeenat, Zaidi, Syed, Talegaonkar, Sushma, Vohra, Divya, Jain, Gaurav, Azeem, Adnan, Jain, Nitin, Lalani, Jigar, Khar, Roop, Ahmad, Farhan·2009·Recent Patents on Drug Delivery & Formulation

DOI 10.2174/187221109787158355

Open this paper in CoChat — free account

Abstract

The brain is a delicate organ, and nature has very efficiently protected it. The brain is shielded against potentially toxic substances by the presence of two barrier systems: the blood brain barrier (BBB) and the blood cerebrospinal fluid barrier (BCSFB). Unfortunately, the same mechanisms that protect it against intrusive chemicals can also frustrate therapeutic interventions. Despite aggressive research, patients suffering from fatal and/or debilitating central nervous system (CNS) diseases, such as brain tumours, HIV encephalopathy, epilepsy, cerebrovascular diseases and neurodegenerative disorders, far outnumber those dying of all types of systemic cancers or heart diseases. The abysmally low number of potential therapeutics reaching commercial success is primarily due to the complexity of the CNS drug development. The clinical failure of many probable candidates is often, ascribable to poor delivery methods which do not pervade the unyielding BBB. It restricts the passive diffusion of many drugs into the brain and constitutes a significant obstacle in the pharmacological treatment of central nervous system (CNS) disorders. General methods that can enhance drug delivery to the brain are, therefore, of great pharmaceutical interest. Various strategies like non-invasive methods, including drug manipulation encompassing transformation into lipophilic analogues, prodrugs, chemical drug delivery, carrier-mediated drug delivery, receptor/vector mediated drug delivery and intranasal drug delivery, which exploits the olfactory and trigeminal neuronal pathways to deliver drugs to the brain, are widely used. On the other hand the invasive methods which primarily rely on disruption of the BBB integrity by osmotic or biochemical means, or direct intracranial drug delivery by intracerebroventricular, intracerebral or intrathecal administration after creating reversible openings in the head, are recognised. Extensive review pertaining specifically, to the patents relating to drug delivery across the CNS is currently available. However, many patents e.g. US63722506, US2002183683 etc., have been mentioned in a few articles. It is the objective of this article to expansively review drug delivery systems for CNS by discussing the recent patents available.

Integrity signals

Registry

Crossref · 10.2174/187221109787158355

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art
MÃ¼ller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,836
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,158
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 965
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
Levin, V. A. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00180a022 · Cited by 817
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
KrolI, R. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00082 · Cited by 585
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Junctions in the meninges and marginal glia.
Nabeshima, S., Reese, T. S., Landis, D. M. D., & Brightman, M. W. (1975) · Journal of Comparative Neurology · doi:10.1002/cne.901640202 · Cited by 444
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications
Rapoport, S. I. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007049806660 · Cited by 428
Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study
Valtonen, S., la Timonen, U., Toivanen, P., Kalimo, H., Kivipelto, L., Heiskanen, O., Unsgaard, G., & Kuurne, T. (1997) · Neurosurgery · doi:10.1097/00006123-199707000-00011 · Cited by 425
Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease
Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 411
Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J.-M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Drug delivery to the central nervous system: A review
Tamargo, R. J., & Brem, H. (1992) · Neurosurgery Quarterly · Cited by 369
Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres
Wang, J., Wang, B. M., & Schwendeman, S. P. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00137-2 · Cited by 351
Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?
García-García, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 326
Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate
Pardridge, W. M., Kang, Y., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 324
Receptor-Mediated Peptide Transport through the Blood-Brain Barrier*
Pardridge, W. M. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-314 · Cited by 319
Implications of the Blood-Brain Barrier and Its Manipulation
Neuwelt, E. A. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0701-3 · Cited by 316
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
Göppert, T. M., & Müller, R. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500071292 · Cited by 299
A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain
Kabanov, A. V., Batrakova, E. V., Melik-Nubarov, N. S., Fedoseev, N. A., Dorodnich, T. Y., Alakhov, V. Y., Chekhonin, V. P., Nazarova, I. R., & Kabanov, V. A. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90199-2 · Cited by 295
Mechanism of Pluronic Effect on P-Glycoprotein Efflux System in Blood-Brain Barrier: Contributions of Energy Depletion and Membrane Fluidization
Batrakova, E. V., Li, S., Vinogradov, S. V., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29254-5 · Cited by 292
The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
Targeted prodrug design to optimize drug delivery
Han, H.-K., & Amidon, G. L. (2000) · AAPS PharmSci · doi:10.1208/ps020106 · Cited by 277
Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials
Alakhov, V. Y., Klinski, E., Li, S., Pietrzyński, G., Venne, A., Batrakova, E. V., Bronich, T. K., & Kabanov, A. V. (1999) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00064-8 · Cited by 266
Breaking Down Barriers
Miller, G. L. (2002) · Science · doi:10.1126/science.297.5584.1116 · Cited by 240
Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
Tamargo, R. J., Myseros, J. S., Epstein, J. I., Yang, M. B., Chasin, M., & Brem, H. (1993) · PubMed · Cited by 222
The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers
Grossman, S. A., Reinhard, C. S., Colvin, O. M., Chasin, M., Brundrett, R. B., Tamargo, R. J., & Brem, H. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.76.4.0640 · Cited by 217
The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial
Brem, H., Ewend, M. G., Piantadosi, S., Greenhoot, J. H., Burger, P. C., & Sisti, M. B. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01060217 · Cited by 209
Visualization of in vitro protein-rejecting properties of PEGylated stealth® polycyanoacrylate nanoparticles
Peracchia, M. T., Harnisch, S., Pinto‐Alphandary, H., Gulik, A., Dedieu, J., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Distribution of nerve growth factor following direct delivery to brain interstitium
Krewson, C. E., Klarman, M. L., & Saltzman, W. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00261-n · Cited by 201
Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma
Hau, P., Fabel, K. S., Baumgart, U., Rümmele, P., Grauer, O. M., Bock, A., Dietmaier, C., Dietmaier, W., Dietrich, J., Dudel, C., et al. (2004) · Cancer · doi:10.1002/cncr.20073 · Cited by 197
Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells
Ramge, P., Unger, R. E., Oltrogge, J. B., Zenker, D., Begley, D. J., Kreuter, J., & von Briesen, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00078.x · Cited by 197
Pluronic P85 Enhances the Delivery of Digoxin to the Brain: In Vitro and in Vivo Studies
Batrakova, E. V., Miller, D. W., Li, S., Alakhov, V. Y., Kabanov, A. V., & Elmquist, W. F. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38781-6 · Cited by 182
Enhanced Tumor Uptake of Carboplatin and Survival in Glioma-bearing Rats by Intracarotid Infusion of Bradykinin Analog, RMP-7
Matsukado, K., Inamura, T., Nakano, S., Fukui, M., Bartus, R. T., & Black, K. L. (1996) · Neurosurgery · doi:10.1097/00006123-199607000-00025 · Cited by 174
Local drug delivery to the brain
Wang, P. P., Frazier, J., & Brem, H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00054-6 · Cited by 167
Development of microspheres for neurological disorders: From basics to clinical applications
Benoît, J., Faisant, N., Venier‐Julienne, M., & Meneï, P. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00250-3 · Cited by 166
Why is the global CNS pharmaceutical market so under-penetrated?
Pardridge, W. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02082-7 · Cited by 144
Combined Use of Carboxyl-Directed Protein Pegylation and Vector-Mediated Blood-Brain Barrier Drug Delivery System Optimizes Brain Uptake of Brain-Derived Neurotrophic Factor Following Intravenous Administration
Pardridge, W. M., Wu, D., & Sakane, T. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981927620 · Cited by 139
New Technologies for Drug Delivery Across the Blood Brain Barrier
Kabanov, A. V., & Batrakova, E. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384826 · Cited by 137
Determinants of Passive Drug Entry into the Central Nervous System
Habgood, M. D., Begley, D. J., & Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007001923498 · Cited by 129
High Intratumoral Accumulation of Stealth Liposomal Doxorubicin in Sarcomas: Rationale for Combination with Radiotherapy
Koukouraki, A. M. I. K. S. (2000) · Acta Oncologica · doi:10.1080/028418600430789 · Cited by 122
Optimizing drug delivery to brain tumors
Greig, N. H. (1987) · Cancer Treatment Reviews · doi:10.1016/0305-7372(87)90048-x · Cited by 119
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres
Roullin, G., Deverre, J.-R., Lemaire, L. P., Hindré, F., Venier‐Julienne, M., Vienet, R., & Benoît, J. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00011-5 · Cited by 105
Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
Yang, M. B., Tamargo, R. J., & Brem, H. (1989) · PubMed · Cited by 91
Drug Targeting into the Central Nervous System by Stereotactic Implantation of Biodegradable Microspheres
Meneï, P., Benoît, J., Boisdron-Celle, M., Fournier, D., Mercier, P., & Guy, G. (1994) · Neurosurgery · doi:10.1227/00006123-199406000-00016 · Cited by 78
Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin
Omori, N., Maruyama, K., Jin, G., Wang, S., Hamakawa, Y., Sato, K., NAGANO, I., Shoji, M., & Abe, K. (2003) · Neurological Research · doi:10.1179/016164103101201508 · Cited by 72
Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
Ewend, M. G., Williams, J. A., Tabassi, K., Tyler, B., Babel, K. M., Anderson, R. C., Pinn, M. L., Brat, D. J., & Brem, H. (1996) · PubMed · Cited by 69
Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?
Ricci, M., Blasi, P., Giovagnoli, S., & Rossi, C. R. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777452461 · Cited by 56
Delivering Peptides to the Central Nervous System: Dilemmas and Strategies
Banks, W. A., Kastin, A. J., & Barrera, C. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015884603456 · Cited by 54
Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema
Tamargo, R. J., Sills, A. K., Reinhard, C. S., Pinn, M. L., Long, D. M., & Brem, H. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.6.0956 · Cited by 54
Polymer implants for drug delivery in the brain
Langer, R. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90030-h · Cited by 53
In vitro effects of brain derived neurotrophic factor released from microspheres
Mittal, S., Cohen, A., & Maysinger, D. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00043 · Cited by 53
Chapter 30 Prodrugs and Site-Specific Chemical Delivery Systems
Bodor, N. S., & Kaminski, J. J. (1987) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61178-1 · Cited by 49
Novel delivery systems fro drug targeting to the brain
Reddy, J. S., & Venkateswarlu, V. (2004) · Drugs of the Future · doi:10.1358/dof.2004.029.01.872585 · Cited by 48
Implantable microencapsulated dopamine (DA): A new approach for slow-release DA delivery into brain tissue
McRae‐Degueurce, A., Hjorth, S., Dillon, L., Mason, D. W., & Tice, T. R. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90607-6 · Cited by 48
Drug delivery via the blood–brain barrier
Edwards, R. H. (2001) · Nature Neuroscience · doi:10.1038/85045 · Cited by 47
Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies.
Walus, L. R., Pardridge, W. M., Starzyk, R. M., & Friden, P. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12894-2 · Cited by 41
Clinical Gene Therapy for Brain Tumors. Liposomal Delivery of Anticancer Molecule to Glioma
Yoshida, J., & Mizuno, M. (2003) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000003655.03671.fa · Cited by 39
Pluronic P85 Block Copolymer Enhances Opioid Peptide Analgesia
WITT, K. A., Huber, J. D., Egleton, R. D., & Davis, T. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039545 · Cited by 29
Intravenous Liposomal Prednisolone Downregulates In Situ TNF-α Production by T-cells in Experimental Autoimmune Encephalomyelitis
Schmidt, J., Metselaar, J. M., & Gold, R. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100915 · Cited by 28
Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH
Wu, J., Yoon, S., Wu, W., & Bodor, N. S. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760089063 · Cited by 24
Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier
Schlosshauer, B., & Steuer, H. (2002) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1568015023357978 · Cited by 23
Successful ventricular application of the miniaturized controlled-delivery Accurel technique for sustained enhancement of cerebrospinal fluid peptide levels in the rat
Boer, G. J., van der Woude, T. P., Kruisbrink, J., & van Heerikhuize, J. J. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90090-6 · Cited by 23
An antisense EGFR oligodeoxynucleotide enveloped in lipofectinR induces growth inhibition in human malignant gliomas in vitro
Sugawa, N., Ueda, S., Nakagawa, Y., Nishino, H., Nosaka, K., Iwashima, A., & Kurimoto, M. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005903002865 · Cited by 20

Sorted by citations

Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,038
Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Booth, R., & Kim, H. (2012) · Lab on a Chip · doi:10.1039/c2lc40094d · Cited by 746
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Fonseca‐Santos, B., Chorilli, M., & Gremião, M. P. D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 320
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305
“…difficulty in delivering agents such as drugs, nucleic acids, proteins, imaging agents and other macromolecules to the CNS across the peripheral barriers, namely blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB), particularly the BBB (Pathan et al., 2009; Wong et al., 2012).”
Background

See all 193

Authors: Pathan, S., Iqbal, Z., Zaidi, S., Talegaonkar, S., Vohra, D., Jain, G., Azeem, A., Jain, N., Lalani, J., Khar, R., & Ahmad, F.
Affiliations: Jamia Hamdard (IN)
Corresponding author: Ahmad, Farhan
ORCID: Iqbal, Zeenat
Zaidi, Syed
Jain, Gaurav
Jain, Nitin
Ahmad, Farhan
Venue: Recent Patents on Drug Delivery & Formulation
Publisher: Bentham Science Publishers Ltd.
Published: 2009-01-01
Volume: 3
Issue: 1
Pages: 71-89
ISSN: 1872-2113 (ISSN-L)
DOI: 10.2174/187221109787158355
OpenAlex: W2163840515
Cited by: 193
References: 76
Citations by year: 2026: 4 · 2025: 6 · 2024: 14 · 2023: 12 · 2022: 17 · 2021: 12 · 2020: 9 · 2019: 14 · 2018: 12 · 2017: 10 · 2016: 16 · 2015: 16 · 2014: 11 · 2013: 16 · 2012: 9
FWCI: 5.31
Type: journal article
Language: en
Open access: closed
Locations: Recent Patents on Drug Delivery & Formulation (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: brain drug delivery, blood-brain barrier, blood-CSF barrier, brain tumors, neurodegenerative diseases, epilepsy, HIV encephalopathy, cerebrovascular disease, prodrugs, intranasal drug delivery, olfactory pathway, receptor-mediated drug delivery, blood-brain barrier disruption, intrathecal drug delivery, intracerebroventricular administration, patents
MeSH terms: Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System Diseases, Pharmaceutical Preparations, Humans, Patents as Topic, Technology, Pharmaceutical, United States, Drug Design, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CNS Drug Delivery Systems: Novel Approaches

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks